Literature DB >> 15476242

Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus.

Andreas Hutloff1, Kerstin Büchner, Karin Reiter, Hans J Baelde, Marcus Odendahl, Annett Jacobi, Thomas Dörner, Richard A Kroczek.   

Abstract

OBJECTIVE: In systemic lupus erythematosus (SLE), the increased generation of memory B cells and plasma cells leads to autoimmune hypergammaglobulinemia and destructive immunoglobulin deposits in the kidneys. We undertook this study to determine the biologic mechanism driving this overactivation of the B cell compartment, which is the central issue in SLE.
METHODS: We used flow cytometry to analyze expression of the T cell-specific inducible costimulator (ICOS) and its ligand (ICOS-L) on B cells obtained from the peripheral blood of SLE patients. We correlated ICOS-L expression with the differentiation status of the B cells using a large panel of surface antigens. In addition, SLE kidneys were analyzed by immunohistology.
RESULTS: We found an increased expression of ICOS on CD4+ as well as CD8+ T cells in SLE. At the same time, we documented a down-regulation of ICOS-L on a high proportion of peripheral blood memory B cells. Based on in vitro experiments, we inferred that this ICOS-L down-regulation on B cells was a signature of recent interaction with ICOS+ T cells in vivo. In the kidneys of SLE patients, we found clusters of B cells and plasma cells in close contact with ICOS+ T cells.
CONCLUSION: Detailed analysis of B cells with down-regulated ICOS-L suggests that ICOS is one of the forces driving the formation of memory B cells and plasma cells in SLE. Furthermore, our identification of plasma cells in areas of T cell-B cell interaction in kidneys suggests that components of a T cell-driven B cell activation process may take place in peripheral tissues in SLE. Copyright 2004 American College of Rheumatology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476242     DOI: 10.1002/art.20519

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  72 in total

1.  In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis.

Authors:  Anthony Chang; Scott G Henderson; Daniel Brandt; Ni Liu; Riteesha Guttikonda; Christine Hsieh; Natasha Kaverina; Tammy O Utset; Shane M Meehan; Richard J Quigg; Eric Meffre; Marcus R Clark
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

Review 2.  [Autoantibodies and antibody-secreting cells].

Authors:  F Hiepe; T Dörner
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

3.  Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  Jérémie Sellam; Corinne Miceli-Richard; Jacques-Eric Gottenberg; Marc Ittah; Frédéric Lavie; Christine Lacabaratz; Nicolas Gestermann; Alexis Proust; Olivier Lambotte; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2006-12-21       Impact factor: 19.103

Review 4.  New insights into the differentiation and function of T follicular helper cells.

Authors:  Cecile King
Journal:  Nat Rev Immunol       Date:  2009-11       Impact factor: 53.106

5.  ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.

Authors:  Jared M Odegard; Leah D DiPlacido; Lark Greenwald; Michael Kashgarian; Dwight H Kono; Chen Dong; Richard A Flavell; Joe Craft
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

6.  CD4(+) T-cell activation is differentially modulated by bacteria-primed dendritic cells, but is generally down-regulated by n-3 polyunsaturated fatty acids.

Authors:  Susanne Brix; Pia Lund; Tanja M R Kjaer; Ellen M Straarup; Lars I Hellgren; Hanne Frøkiaer
Journal:  Immunology       Date:  2009-11-11       Impact factor: 7.397

7.  Inducible costimulator expression regulates the magnitude of Th2-mediated airway inflammation by regulating the number of Th2 cells.

Authors:  Bryan S Clay; Rebecca A Shilling; Hozefa S Bandukwala; Tamson V Moore; Judy L Cannon; Andrew A Welcher; Joel V Weinstock; Anne I Sperling
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

Review 8.  B cells in autoimmunity.

Authors:  Thomas Dörner; Annett M Jacobi; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

9.  Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndrome.

Authors:  Barbara Cassani; Pietro Luigi Poliani; Veronica Marrella; Francesca Schena; Aisha V Sauer; Maria Ravanini; Dario Strina; Christian E Busse; Stephan Regenass; Hedda Wardemann; Alberto Martini; Fabio Facchetti; Mirjam van der Burg; Antonius G Rolink; Paolo Vezzoni; Fabio Grassi; Elisabetta Traggiai; Anna Villa
Journal:  J Exp Med       Date:  2010-06-14       Impact factor: 14.307

10.  Follicular helper T cells are required for systemic autoimmunity.

Authors:  Michelle A Linterman; Robert J Rigby; Raphael K Wong; Di Yu; Robert Brink; Jennifer L Cannons; Pamela L Schwartzberg; Matthew C Cook; Giles D Walters; Carola G Vinuesa
Journal:  J Exp Med       Date:  2009-02-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.